Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05020535 · ClinicalTrials.gov registry record · Phase 2
Biomarker and Edema Attenuation in IntraCerebral Hemorrhage (BEACH)
A Phase 2 study of Intracerebral Hemorrhage, sponsored by Johns Hopkins University.
- Recruiting
- Registry status
- Phase 2
- Development phase
- 120
- Enrollment target
- 11
- Study locations
NCT05020535: Recruiting Phase 2 study of Intracerebral Hemorrhage, sponsored by Johns Hopkins University.
NCT05020535 is a Phase 2 study of Intracerebral Hemorrhage that is actively recruiting participants, run by Johns Hopkins University. The registered enrollment target is 120 participants, below the 1,102-participant average among 31 other Intracerebral Hemorrhage trials with a reported enrollment target (89% lower). The trial reports 11 study locations across 10 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05020535, a Phase 2 study of Intracerebral Hemorrhage, is actively recruiting participants, sponsored by Johns Hopkins University.
- RECRUITING
- Registry status
- Phase 2
- Development phase
- 120 participants
- Enrollment target
- 11
- Study locations
Study Summary
This first-in-patient phase 2a pilot study will assess the safety and tolerability of MW01-6-189WH (hereafter called MW189) in patients with Intracerebral Hemorrhage (ICH).
Primary Outcome
Assess the safety and tolerability of MW189 for patients as determined by the rate of death during the treatment period.
Conditions Studied
Interventions
- OTHER Saline
- DRUG MW189
Study Locations (11)
Texas
- University of Texas Houston - Houston
- University of Texas San Antonio - San Antonio
Alabama
- University of Alabama Birmingham - Birmingham
California
- Stanford University - Palo Alto
Connecticut
- Yale New Haven Hospital - New Haven
Florida
- Cleveland Clinic Florida - Stuart
Kentucky
- University of Kentucky - Lexington
Maryland
- Johns Hopkins Hospital - Baltimore
New Mexico
- University of New Mexico - Albuquerque
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 120 participants |
| Start Date | 2022-10-10 |
| Est. Completion | 2027-10-01 |
| Phase | Phase 2 |
What NCT05020535 shows while recruiting
NCT05020535 is an interventional study that assigns participants to a tested intervention. The registered 120 participants enrollment target is mid-sized for trials with a published cap, below the 1,102-participant average among 31 other Intracerebral Hemorrhage trials with a reported enrollment target (89% lower).
The record links to 1 condition, with Intracerebral Hemorrhage appearing as the primary indexed condition, and to 2 interventions - of which Saline is the first listed.
NCT05020535 lists 11 locations in 10 states (Texas, Alabama, California).
Frequently Asked Questions
What is clinical trial NCT05020535 about?
NCT05020535 is a clinical study titled "Biomarker and Edema Attenuation in IntraCerebral Hemorrhage (BEACH)". This first-in-patient phase 2a pilot study will assess the safety and tolerability of MW01-6-189WH (hereafter called MW189) in patients with Intracerebral Hemorrhage (ICH).
What is the current status of trial NCT05020535?
This trial is currently recruiting. It is a Phase 2 study. The enrollment target is 120 participants. The study started on 2022-10-10. Estimated completion is 2027-10-01.
What conditions does trial NCT05020535 study?
This clinical trial studies the following conditions: Intracerebral Hemorrhage.
What interventions are being tested in trial NCT05020535?
The interventions under investigation include: Saline (OTHER), MW189 (DRUG).
Who is sponsoring clinical trial NCT05020535?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05020535 being conducted?
This trial has 11 study locations across Alabama, California, Connecticut, Florida, Kentucky. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Intracerebral Hemorrhage
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05020535's enrollment target sits among peer trials
120 20th of 31 higher than 11 of 31 other Intracerebral Hemorrhage trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Intracerebral Hemorrhage trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Regulating Blood Pressure During Recovery From Intracerebral Hemorrhage and Ischemic Stroke
RECRUITING · Phase 2
-
The Spot Sign for Predicting and Treating ICH Growth Study
COMPLETED · Phase 2
-
Hemodynamic ABI Monitor
RECRUITING
-
Determinants of Incident Stroke Cognitive Outcomes and Vascular Effects on RecoverY
RECRUITING
-
Recombinant Factor VIIa (rFVIIa) for Hemorrhagic Stroke Trial - Part 2
RECRUITING · Phase 3
-
Transitions of Care for Stroke Patients
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01174108 · 120 participants · Phase 2
Allogeneic Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia and Other Bone Marrow Failure Syndromes Using G-CSF Mobilized CD34+ Selected Hematopoietic Precursor Cells Co-Infused With a Reduced Dose of Non-Mobilized Donor T-cells
- NCT01627301 · 120 participants · NA
Sympathetic Overactivity in Post-traumatic Stress Disorder
- NCT02025023 · 120 participants · Phase 3
Local 5-Fluorouracil Injection for the Treatment of Chalazia: A Prospective, Comparative Study
- NCT02128906 · 120 participants · Phase 2
Radiotherapy With Cisplatin vs. Docetaxel-cetuximab in HNSCC: ERCC1 Biomarker Enrichment and Interaction Design
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI